Postgraduate school for Dr. Andrew
School of specialization in gynecology and obstetrics the for Dr. Andrew Oryono, MD in Uganda - Third year
01 August 2014 - 31 July 2015
Description of the project
AFRON is funding the studies of Dr. Andrew Oryono, a young doctor at St. Joseph Hospital in Kitgum which led, together with our staff of AFRON, the screening campaign in January 2012.
In August 2012, Dr. Andrew registered in the Specialization Course in Obstetrics and Gynecology at the Mbarara University of Science and Technology (Uganda) and is currently attending a successful final year of study, after which he will be grant a diploma.
Dr. Oryono’s training is part of a larger project that AFRON is planning in collaboration with the Health Department at St. Joseph''s Hospital in Kitgum.
The final objective is the opening of a Permanent Screening Centre in Kitgum, managed by Dr. Oryono, to be assisted by a team of four obstetrical nurses (who are currently attending nursing school). The Screening Centre will be the reference point in northern Uganda for the prevention of cervical and breast cancer. The women of the district will not only have the opportunity to be seen by a doctor during the screening campaign organized by AFRON, they will also have a centre available to them throughout the year.
• Increase awareness of women''s cancer in the local community
• For women in northern Uganda, provide continued access to technologies for early
detection and screening of breast and cervical cancer
• Strengthen the ability of health care professionals to detect and treat breast and cervical
• Creation of a database and registry for cancer, in collaboration with the Uganda Cancer Institute and the Ministry of Health of Uganda
Direct: Dr. Andrew Oryono and St. Joseph Hospital
Indirect: the local community and in particular, the female population of northern Uganda
St. Joseph Hospital: www.sjhkitgum.org
Cost of the project: € 8,000 per year for three years
The third year of specialization (August 2014-September 2015) was funded through an unconditional contribution by Takeda Italy.